What is pathophysiology of Alzheimer?

['مڠهادڤي لاڤورن اين']

ڤاتوڤيسيوولوڬي الزهايمر ايه؟

ڤاتوڤيسيوولوڬي كاءداءن الزهايمر (AD) اداله ڤروسيس يڠ كومڤليك يڠ مڠڬوناكن ڤمبڠكڠن ڤروتين يڠ ايبورنل، ڤمباڠونن، دان ڤڠڬونأن نيرونل.

دوا ciri utama AD adalah kehadiran plak amyloid-beta (Aβ) dan kusut neurofibrillary (NFT) di otak.

ڤلايك بيه-اميلويد دڤامبڠكن كتيک ڤريڬمن ڤروتين ڤريكورسور بيه-اميلويد (APP) دڤامبڠكن اوليه اينزايم اونتوق ممبنتو بيبتيد بيه-اميلويد.

Peptide-peptide nyo meumpukan dan membentuk fibril-fibril hana larut yang menumpuk di lua neuron, meungganggu komunikasi sel-ke-sel dan meulah kematian neuron.

akumulasi plak Aβ dianggap sebagai salah satu peristiwa paling awal dalam perkembangan AD, dan dipercaya berkontribusi pada proses neurodegeneratif. akumulasi plak Aβ dianggap sebagai salah satu peristiwa paling awal dalam perkembangan AD, dan dianggap berkontribusi pada proses neurodegeneratif.

ڤڠڬڠڬوڠ نيروفيبريلري دڤرتيمبڠكن كتيک ڤروتين تاو منجادي هيبرفوسفوريلات دان ممبنتو فيلامن يڠ ايبورنل دالم نيورون.

ڤڠڬونجوڠ اين مڠڬونجوڠكن ڤڠڬوناان نورمال ميكروتوبول، يڠ ڤنتيڠ اونتوق ڤڠوروسن ڤڠوروسن دان ماتريال لاين دالم نورون.

ڤڠڬڠڬوان اخيرڽ ممباوا ك موت نيرون يڠ دتاڠڬي

التهاب هم د AD په پاتو فزيولوژي کي رول لوبوي.

سيستم imun ماڠڬوناكن ڤمبڠكوتن ڤلاك Aβ دان NFT دڠن ممڤرلواركن sitokin pro-inflammatory، يڠ موڠكين ممڤوڽاءي كاسيهن كڤد neuron.

سلاين، اد بوقتي يڠ مڠڬنتيكن ستريس اوكسيداتيف، ديسفوكسي ميتوكوندريا، ڠن ميتابوليسمى گلوكوز يڠ دتڠڬه مڠڬنتيكن ڤاتوفيزيولوڬي AD.

فاكتور-فاكتور اين موڠكين ممباوا كدوا-دوا ڤڠڬوناان نيرونل دان كمواتن، مڠوروسكن ڤروسيس كلوارڬ.

Secara keseluruhan, patofisiologi AD adalah interaksi kompleks dari beberapa faktor yang akhirnya mengarah pada penurunan progresif fungsi kognitif dan kehilangan memori yang menjadi ciri khas penyakit.

['ريفرنس']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.

Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. , 13 Suppl 3 (): S106-14.

Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.

Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.

Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.

Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.

Raskind MA, Peskind ER: Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 Suppl 3 (): 54-60.

Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.

Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.

['ڤڠهادڤن: ميديك']

['ويب سايت اين دبريكن اونتوق ڤڠاجرن دان معلومت سهيڠڬ دان تيدق ممڤوڽاءي نصيحت ميديكل اتاو ڤرخدمتن ڤروفيسيونل.']

['معلومت يڠ دبريكن تيدق بوليه دڬوناكن اونتوق ممڤوڽاءي اتاو ممباوا ڤروبليم كصيحتن اتاو كمرضن، دان اورڠ-اورڠ يڠ ممڤوڽاءي نصيحت ميديكل ڤرسوداران بوليه مڠيكوت دوكتور يڠ مڠيكوت.']

['سوده دتنتوكن، jaring saraf يڠ ممبنتو جواڤن كڤد سوألن، تيدق ساڠت ڤاليڠ ڤاليڠ ڤاليڠ ڤاليڠ ڤاليڠ كتيک دتڠكڤ كڤد كونتينن نوميريک. سڤرتي، ڤندودوق اورڠ يڠ دڤرچاياڬوسكن دڠن كمرڬانن خاص.']

['Slalu seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Jika anda pikir anda mungkin mengalami keadaan darurat medis, hubungi 911 atau pergi ke ruang gawat darurat terdekat segera. Tidak ada hubungan dokter-pasien yang dibuat oleh situs web ini atau penggunaannya. BioMedLib maupun karyawannya, maupun kontributor situs web ini, tidak membuat representasi apapun, secara eksplisit atau implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya. BioMedLib tidak akan memberikan jaminan, baik secara eksplisit maupun implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya. BioMedLib tidak akan memberikan jaminan, baik secara eksplisit maupun implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya. BioMedLib tidak akan memberikan jaminan, baik secara eksplisit maupun implisit, sehubungan dengan informasi yang disediakan di sini atau penggunaannya.']

['ڤڠهادڤن: حق ڤنوليس']

['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) ممبري ڤڠاجرن اونتوق ڤميمڤين حق ڤنوليس يڠ مڠڬنتيكن بهاوا ماتريال يڠ دڤرچايا?? ي د انتارنيت مڠڬوناكن حقڽ دالم ڤرلمباڬان حق ڤنوليس اميريكا.']

['اڤابيلا ديري مڠڬنتيكن دڠن كصيحتن يڠ باءيق بهاوا ستياڤ كونتين اتاو ماتريال يڠ دڤاوڤونكن دڠن ڤڠڬوناان ويب اتاو ڤرخدمتن ديري مڠڬوناكن حق ڤنوليسن ديري، ديري (اتاو اڬين ديري) موڠكين مڠوروسكن كيت ساتو كپاتا ن مڠمبيل ستياڤ كونتين اتاو ماتريال دڤاوڤون اتاو كلوارڬ كيت.']

['ڤڠاجرن هاروس دجوال دڠن توليسن ملالوءي ايميل (تڠه سيكشن "Kontakt" اونتوق ايديريس ايميل)']

['DMCA ممرلوكن ڤڠاجرن ڤڠهيناان حق ڤنوليسن ترماسوق معلومت يڠ منوروت: (1) ڤنوليسن كراجا?? ن حق ڤنوليسن يڠ منجادي موضوع ڤڠهيناان ترماسوق معلومت (2) ڤنوليسن كونتينن يڠ ترماسوق ڤڠهيناان دان معلومت يڠ ممڤرلوكن كيت منچاري معلومت (3) معلومت ڤڠاتوهن كيت ترماسوق ايدريس، نومبر تيليفون دان ايدريس ايميل (4) كپاتا?? ن كيت يڠ ممڤرلوكن كڤد كيت كران كيت برهارڤ ڤڠهيناان يڠ دڤنوليسكن تيدق دأوتوريساسي اوليه ڤملكن حق ڤنوليسن اتاو اڬينڽ اتاو اوليه ڤڠڬونا?? ن ايستري.']

['(5) pernyataan awak, ditandatangani di bawah hukuman sumpah palsu, bahwa informasi dalam pemberitahuan adalah akurat dan awak memiliki wewenang untuk menegakkan hak cipta yang diklaim dilanggar; ']

['ڠن (6) ساتو ڤنوليسن فيزيک اتاو ايليکترونيک دري ڤميمڤين حق اوڤاي اتاو سأورڠ يڠ دأذنکن اونتوق مڠݢوناکن ڤميمڤين حق اوڤاي. ']

['كران تيدق ممڤوڽاءي سموا معلومت يڠ دڤرتوان اكن ممباوا كڤد ڤڠڬوناان كڤد كڤدأنن.']

['ڤرتوبوهن']

['Tulung kirimi kami email dengan pertanyaan/usulan apapun.']

What is pathophysiology of alzheimer?

The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.

The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.

Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.

These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.

The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.

Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.

These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.

The tangles eventually lead to the death of the affected neurons.

Inflammation also plays a role in the pathophysiology of AD.

The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.

Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.

These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.

Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.